摘要
The development of therapies for lysosomal storage disorders has created a need for biochemical markers to monitor the efficacy of therapy and methods to quantify these markers in biologic samples. In Pompe disease, the concentration of a tetrasaccharide, consisting of four glucose residues, is reputedly increased in urine and plasma, but faster and more sensitive methods are required for the analysis of this, and other oligosaccharides, from biologic fluids.
| 源语言 | English |
|---|---|
| 页(从-至) | 131-9 |
| 页数 | 9 |
| 期刊 | Clinical Chemistry |
| 卷 | 48 |
| 期 | 1 |
| 出版状态 | Published - 1月 2002 |
指纹
探究 'Determination of oligosaccharides in Pompe disease by electrospray ionization tandem mass spectrometry' 的科研主题。它们共同构成独一无二的指纹。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver